Hsbc Holdings PLC Has $54.68 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Hsbc Holdings PLC decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 4.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 185,216 shares of the biotechnology company’s stock after selling 7,727 shares during the quarter. Hsbc Holdings PLC owned 0.25% of Axon Enterprise worth $54,678,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Personalized Indexing Management LLC grew its holdings in shares of Axon Enterprise by 7.8% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 6,354 shares of the biotechnology company’s stock worth $1,843,000 after purchasing an additional 462 shares during the last quarter. Amalgamated Bank grew its holdings in shares of Axon Enterprise by 0.5% during the second quarter. Amalgamated Bank now owns 15,347 shares of the biotechnology company’s stock worth $4,516,000 after purchasing an additional 71 shares during the last quarter. Meiji Yasuda Asset Management Co Ltd. grew its holdings in shares of Axon Enterprise by 11.2% during the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 1,112 shares of the biotechnology company’s stock worth $327,000 after purchasing an additional 112 shares during the last quarter. SYSTM Wealth Solutions LLC grew its holdings in shares of Axon Enterprise by 86.1% during the second quarter. SYSTM Wealth Solutions LLC now owns 3,844 shares of the biotechnology company’s stock worth $1,131,000 after purchasing an additional 1,778 shares during the last quarter. Finally, Total Clarity Wealth Management Inc. grew its holdings in shares of Axon Enterprise by 4.3% during the second quarter. Total Clarity Wealth Management Inc. now owns 1,224 shares of the biotechnology company’s stock worth $360,000 after purchasing an additional 50 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In related news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the sale, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the sale, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $380.99, for a total value of $380,990.00. Following the sale, the director now directly owns 27,259 shares of the company’s stock, valued at $10,385,406.41. The disclosure for this sale can be found here. In the last three months, insiders sold 317,981 shares of company stock valued at $115,662,734. 6.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on AXON shares. Northland Securities boosted their price target on Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Barclays upped their target price on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Needham & Company LLC reiterated a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a report on Wednesday, August 7th. Jefferies Financial Group started coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 target price on the stock. Finally, Robert W. Baird increased their price target on Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a report on Tuesday, September 10th. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $365.38.

Check Out Our Latest Stock Report on AXON

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $393.29 on Friday. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a twelve month low of $189.12 and a twelve month high of $393.58. The stock’s 50 day moving average is $346.03 and its 200-day moving average is $316.70. The firm has a market capitalization of $29.72 billion, a price-to-earnings ratio of 115.00, a PEG ratio of 10.34 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. The business had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. Axon Enterprise’s quarterly revenue was up 34.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.80 EPS. Sell-side analysts forecast that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.